Show metadata Hide metadata

(19)

(11)

2 819 722

(13)

(51)

IPC

A61K31/454(2006-01-01)

C07D401/06(2006-01-01)

A61P11/14(2006-01-01)

(21) (22)

Application

2022107184, 2022-03-18

(24)

Start date

2022-03-18

(22)

Actual filing date

2022-03-18

(45)

Published

2024-05-23

(72)

Inventor

Globenko Aleksandr AleksandrovichZakharova Ekaterina KonstantinovnaGolubeva Natalya AleksandrovnaShmeleva Varvara NikolaevnaNebolsin Vladimir Evgenevich

(73)

Holder

Obshchestvo S Ogranichennoj Otvetstvennostyu Intellekt"Nebolsin Vladimir Evgenevich

USE OF 1-(2-(1N-IMIDAZOL-4-YL)ETHYL)PIPERIDINE-2,6-DIONE FOR TREATING COUGH CAUSED BY VIRAL INFECTIONS Russian patent published in 2024 - IPC A61K31/454 C07D401/06 A61P11/14

Abstract RU 2819722 C2

FIELD: medicine; pharmaceutics.

SUBSTANCE: invention refers to pharmaceutics and medicine, namely to cough treatment and prevention. Disclosed is the use of a pharmaceutical composition containing 1-(2-(1H-imidazol-4-yl)ethyl)piperidine-2,6-dione 5.0–25.0 wt.% and auxiliary substances, wt.%: microcrystalline cellulose 35.0–50.0, sodium carboxymethyl starch 0.5–1.0, talc 0.1–0.5, magnesium stearate 0.1–1.5, anhydrous lactose 35.0–45.0, for the treatment and prevention of cough in a human patient.

EFFECT: effective and safe treatment of cough, including that caused by viral infections.

4 cl, 2 ex

Similar patents RU2819722C2

Title	Year	Author	Number
NEW CRYSTAL FORM OF 1-(2-(1H-IMIDAZOL-4-YL)ETHYL)PIPERIDINE-2,6-DIONE AND ITS PHARMACEUTICAL APPLICATION	2022	Golubeva Natalya Aleksandrovna Pereverzev Anton Petrovich Nebolsin Vladimir Evgenevich	RU2812541C1
USE OF 1-[2-(1-METHYLIMIDAZOL-4-YL)-ETHYL]PERHYDROAZINE-2,6-DIONE FOR TREATING COVID-19	2021	Nebolsin Vladimir Evgenevich	RU2823973C2
USE OF GLUTARIMIDE DERIVATIVE FOR THERAPY OF DISEASES ASSOCIATED WITH ABERRANT ACTIVITY OF INTERLEUKIN-6	2020	Nebolsin Vladimir Evgenevich	RU2774928C2
USE OF A DERIVATIVE GLUTARIMIDE TO OVERCOME RESISTANCE TO STEROIDS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT SIGNALING OF INTERFERON GAMMA	2018	Nebolsin Vladimir Evgenevich	RU2712281C1
NEW CRYSTAL FORM OF 1-[2-(1-METHYLIMIDAZOL-4-YL)ETHYL]PERHYDROAZINE-2,6-DIONE AND ITS PHARMACEUTICAL USE	2022	Nebolsin Vladimir Evgenevich	RU2809992C1
PHARMACEUTICAL COMPOSITION 1-[2-(1-METHYLIMIDAZOL-4-YL)-ETHYL]PERHYDROAZINE-2,6-DIONE FOR THERAPY OF RESPIRATORY DISEASES	2021	Nebolsin Vladimir Evgenevich Golubeva Natalya Aleksandrovna Shmeleva Varvara Nikolaevna Kisel Aleksej Nikolaevich	RU2823588C2
PHARMACEUTICAL COMPOSITION OF N,N'-BIS[2-(1H-IMIDAZOL-4-YL)ETHYL]MALONAMIDE	2022	Nebolsin Vladimir Evgenevich	RU2818073C2
NOVEL TACHYKININ RECEPTOR ANTAGONIST AND USE THEREOF	2018	Nebolsin Vladimir Evgenevich	RU2697414C1
NOVEL CRYSTALLINE FORM OF N,N'-BIS-[2-(1N-IMIDAZOL-4-YL)ETHYL]PROPANEDIAMIDE AND PHARMACEUTICAL USE THEREOF	2022	Nebolsin Vladimir Evgenevich	RU2823162C2
NOVEL 2-(IMIDAZOL-4-YL)-ETHANAMIDE PENTANEDIOIC-1,5 ACID COMPOSITIONS FOR TREATING AND PREVENTING VIRAL DISEASES	2020	Nebolsin Vladimir Evgenevich Pereverzev Anton Petrovich	RU2746692C1

RU 2 819 722 C2

Authors

Globenko Aleksandr Aleksandrovich

Zakharova Ekaterina Konstantinovna

Golubeva Natalya Aleksandrovna

Shmeleva Varvara Nikolaevna

Nebolsin Vladimir Evgenevich

Dates

2024-05-23—Published

2022-03-18—Filed